Survey finds 25% of adults suspect they have undiagnosed ADHD

A new national survey of 1,000 American adults commissioned by The Ohio State University Wexner Medical Center and College of Medicine finds that 25% of adults now suspect they may have undiagnosed ADHD but only 13% have talked to their doctor about it.

Mouse study explores 3D structure of DNA in nerve cells

New mouse model research led by scientists at The Ohio State University Wexner Medical Center, College of Medicine and Imperial College London explored how nerve cells repair themselves, which could lead to new treatments for nerve injuries.

Chemotherapy disrupts gut microbiome in patients with breast cancer

“For the first time ever, our Intelligut Study found that the gut microbiome has been implicated in cognitive side effects of chemotherapy in humans,” said senior author Leah Pyter, associate professor of psychiatry and neuroscience with The Ohio State University Wexner Medical Center and College of Medicine.

Using self-administered cognitive test in primary care offices increased early diagnosis of cognitive disorders by six times

Researchers at The Ohio State University Wexner Medical Center and College of Medicine have found that the practical and brief SAGE test was easily incorporated into primary care providers’ visits.
The free Self-Administered Gerocognitive Exam (SAGE) developed by Ohio State researchers is designed to detect early signs of cognitive, memory or thinking impairments. It evaluates a person’s thinking abilities and helps physicians to know how well their brain is working.

Wexner Medical Center among first in nation to administer new gene therapy for ALS

The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

‘Years of Life Lost’ to unintentional drug overdose in adolescents spikes during pandemic

COLUMBUS, Ohio – The first year of the COVID-19 pandemic saw a 113% increase in the “Years of Life Lost” among adolescents and young people in the United States due to unintentional drug overdose, according to researchers at The Ohio State University Wexner Medical Center and College of Medicine.

Innovative Gene Therapy ‘Reprograms’ Cells To Reverse Neurological Deficiencies

A new method of gene therapy is helping children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities. The study was led by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine.

Ohio State Among First In Nation To Implant New Deep-Brain Stimulation Device

COLUMBUS, Ohio – The team of neurologists and neurosurgeons at The Ohio State University Wexner Medical Center and its Neurological Institute are among the first in the nation to implant a new deep-brain stimulation (DBS) device that will help improve the quality of life of patients with Parkinson’s disease.

Survey Finds American’s Social Media Habits Changing As National Tensions Rise

As national tensions rise, a new national survey of 2,000 people commissioned by The Ohio State University Wexner Medical Center finds more Americans are adjusting how they use social media platforms.

Mouse Study Shows Spinal Cord Injury Causes Bone Marrow Failure Syndrome

Researchers at The Ohio State University Wexner Medical Center and College of Medicine found that spinal cord injuries in mice cause an acquired bone marrow failure syndrome that may contribute to chronic immune dysfunction.

Ohio State Study Finds Oral Health, Diet May Improve Psoriasis

Dental health and diet may have an impact on the development and severity of psoriasis, according to a study by dermatologists at The Ohio State University Wexner Medical Center. Psoriasis is a skin disease that causes thick, itchy patches of red skin with silvery scales and affects more than 8 million Americans.